CSL LIMITED
Patent Owner
Stats
- 69 US PATENTS IN FORCE
- 11 US APPLICATIONS PENDING
- Feb 13, 2018 most recent publication
Details
- 69 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 1,130 Total Citation Count
- Jul 20, 1992 Earliest Filing
- 53 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
Publication #
Title
Filing Date
Pub Date
Intl Class
2017/0362,328 METHOD OF TREATMENT OF PHILADELPHIA CHROMOSOME POSITIVE LEUKEMIAAug 30, 17Dec 21, 17[A61K, C07K]
2017/0137,536 INHIBITORY ANTI-FACTOR XII/XIIA MONOCLONAL ANTIBODIES AND THEIR USESNov 04, 16May 18, 17[C07K]
2017/0129,938 PRODUCTION OF RECOMBINANT VON WILLEBRAND FACTOR IN A BIOREACTORApr 14, 15May 11, 17[C12P, C07K]
2017/0121,423 INHIBITORY ANTI-FACTOR XII/XIIA MONOCLONAL ANTIBODIES AND THEIR USESNov 04, 16May 04, 17[C07K]
2017/0042,981 HALF-LIFE EXTENDED FACTOR FVIIA PROTEIN FOR PREVENTION AND TREATMENT OF BLEEDING AND DOSING REGIMENS THEREFORMar 30, 15Feb 16, 17[A61K]
2016/0346,366 FUSION PROTEINS COMPRISING FACTOR IX FOR PROPHYLACTIC TREATMENT OF HEMOPHILIA AND METHODS THEREOFDec 01, 14Dec 01, 16[A61K, C12N, C07K]
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
9878017 Covalent complex of von Willebrand Factor and factor VIII, compositions, and uses relating theretoApr 22, 14Jan 30, 18[A61K, C07K]
9856325 Nucleic acids encoding inhibitory anti-factor XII/XIIa monoclonal antibodiesNov 04, 16Jan 02, 18[C07H, A61K, C07K]
9856326 Methods of administering inhibitory anti-factor XII/XIIA monoclonal antibodiesNov 04, 16Jan 02, 18[A61K, C07K]
9803008 Method of treating diabetic nephropathy by administering antibodies to vascular endothelial growth factor B (VEGF-B)Nov 28, 14Oct 31, 17[A61K, C12N, C07K]
9777062 High affinity antibody antagonists of interleukin-13 receptor alpha 1May 20, 16Oct 03, 17[C07H, C12P, C07K]
9758585 Compositions and methods for targeting type 1 interferon producing cellsFeb 09, 15Sep 12, 17[A61K, C07K]
9518127 Inhibitory anti-factor XII/XIIA monoclonal antibodies and their usesJul 20, 12Dec 13, 16[A61K, C07K]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2016/0304,616 METHOD OF TREATMENT OF PHILADELPHIA CHROMOSOME POSITIVE LEUKEMIAAbandonedJun 27, 16Oct 20, 16[A61K, C07K]
2015/0093,355 METHOD OF TREATMENT OF PHILADELPHIA CHROMOSOME POSITIVE LEUKEMIAAbandonedOct 17, 14Apr 02, 15[A61K]
2014/0302,083 PORPHYROMONAS GINGIVALIS POLYPEPTIDES AND NUCLEOTIDESAbandonedJan 23, 14Oct 09, 14[A61K, C07K]
2014/0178,364 COMPOSITIONS AND METHODS FOR TARGETING TYPE 1 INTERFERON PRODUCING CELLSAbandonedAug 14, 13Jun 26, 14[C07K]
2014/0086,912 HUMANIZED ANTI-INTERLEUKIN 3 RECEPTOR ALPHA CHAIN ANTIBODIESAbandonedSep 24, 13Mar 27, 14[C07K]
2012/0244,116 METHOD OF TREATMENT OF PHILADELPHIA CHROMOSOME POSITIVE LEUKAEMIAAbandonedOct 01, 10Sep 27, 12[A61K, A61P]
2011/0052,574 METHOD OF INHIBITION OF LEUKEMIC STEM CELLSAbandonedDec 04, 08Mar 03, 11[A61K, C12N, A61P, C07K]
7786260 Polypeptide fragments comprising c terminal portion of helicobacter catalaseExpiredOct 13, 00Aug 31, 10[A61K, C07K]
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.